Commercialization: Page 116
-
PharmaVoice Team/PharmaVoice
Cover
December 2003 The forum for the industry executive PHASE IV TRIALS Balancing marketing and science adventuring forth with John Patton Marketing to nps and pas Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
NPs and PAs: A Growing Sphere of Influence
By Elisabeth Pena Sales reps are coming to us and providing us with good educational information, as well as the latest research data. Mary Kay Tucker The number of nurse practitioners and physician assistants empowered with the authority to prescribe medication is increasing annually. Addressing...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
John Patton: A Lifetime of Adventure
by Kim Ribbink A Lifetime of Adventure With a number of ground- breaking technologies under its belt, Nektar Therapeutics is vying to be the No. 1 drug-delivery company in the world. And the company’s cofounder and chief scientific officer, John Patton, Ph.D., has led the push to unearth solution...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Solutions From PHT Provide Clinical Trial Savings and Flexibility Two recently launched offerings from PHT Corp., LogPad Phone and the Technology Transfer Program, aim to make the electronic capture of clinical-trial information e...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, And R&D Trends Affecting the Healthcare Industry Doctors Prefer Details by Specialty Reps In the past three years, specialty sales representatives have become an increasingly important promotional investment for pharmaceutical companies, according to Verispanís l...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
What can you say about a nearly 12-year-old brand that has less then half the share of the category leader and is indicated for a condition that even those who have been diagnosed have trouble paying attention to? The brand is Zocor, the asymptomatic condition is hypercholesterolemia, and the ans...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Dorothy Smith: Education, the Best Medicine
education, the best medicine Dr. Dorothy Smith has devoted her career to consumer healthcare education. She began by shaking up the role of the pharmacist by pushing for patient-counseling programs. Today, she continues to work tirelessly to ensure that consumers are informed and involved in deci...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Diagnostics and Devices: A Different Arena
Diagnostics and Devices different arena By Elisabeth Pena With smaller marketing budgets and a more focused, cost-conscious audience, the device and diagnostic sectors face challenges that require different strategies from their pharmaceutical counterparts. A number of world events bode well for ...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Data Strategy: Cracking the Marketing Code
Data Strategy Cracking the Marketing Code The creation of relevant marketing messages often relies on data that have been appropriately aggregated and analyzed. A well-conceived and implemented data strategy provides for a more targeted approach that ensures better results and increases return on...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Paul Harris Creating Memorable Visual Branding This past year, the pages of this publication and others in the pharmaceutical advertising niche have explored at length the matter of creativity in pharmaceutical ads. Theyíve addressed such questions as: Why aren’t pharma ads more cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies The HBA – A National Brand The Healthcare Businesswomenís Association has undergone a reorganization and created a new Northeast Corridor Metro Chapter to better serve its members. The Healthcare Businesswomen’s Association (HBA)...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Sea Change
Sea Change Turning the tide The Product Life-Cycle Management Wave Commonly thought of as a strategy for the end-phase of a drug, life-cycle management increasingly is being deployed by life-sciences executives earlier in the development phases to maximize product value, provide greater benefits ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
executive appointments and promotions in the healthcare industry Pharma POOL Robert Boisclair Dr. Richard Bowles Steve Chellevold Mary-Frances Faraji Brent Saunders Schering-Plough Announces Senior-Level Management Changes Schering-Plough, Kenilworth, N.J., has made senior-level management change...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
talent pool executive appointments and promotions in the healthcare industry Pharma POOL Robert Bertolini Schering-Plough Appoints Executive VP, Chief Financial Officer Schering-Plough has appointed Robert J. Bertolini as executive VP and chief financial officer. He also serves on the Schering-Pl...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Parents Hesitant to let Children Participate in Clinical Trials Only one in four U.S. adults would consider allowing their children to participate in clinical trials. This is one of the results of a Harris Interact...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Developing a CDISC Intelligence Quotient
Developing a CDISC Intelligence Quotient Some CDISC members envision a time in the future when at least three of the CDISC standards will be combined into one. Until then, the question remains: what does CDISC-compliant mean to you? By breaking down the components of CDISC, people can better unde...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies Corbett Accel Healthcare Adds New Interactive Unit The new business unit, Kinect, fuses strategy with design and technology. Corbett Accel Healthcare Group has expanded its interactive offerings with the establishment of Kinect. ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 10-11 Clarifying the Regulatory Framework of Pharmaceutical Marketing Philadelphia For more information, contact Anne Marie Coluccio, PTi international, at 212-661-3500 ext. 3229, e-mail [email protected], or visit pti-international.com. January 24-25 Manage the Cost of Spec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
To Err is Human How Personal Health Records Can help It seems that a day doesn’t go by without hearing about health information technology (HIT). The healthcare system often is touted as one of our nation’s worst big-industry offenders when it comes to implementing HIT. This lack of HIT is to bla...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Raise your Voice Letters Medicare Drug Benefit – A Terrible Mistake The Medicare prescription drug bill voted on by Congress in November 2003 was a terrible mistake that will dearly cost our children and grandchildren. This was not a Medicare reform bill. This was barely a Medicare prescription d...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Letter From The Editor More than 40% of executives recently surveyed by Datamonitor believe their companies are failing to commit adequate time and resources to portfolio management and futhermore, 25% believe their organizations have little ability to implement and execute portfolio management e...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Prioritizing the pipeline: The role of portfolio management Increased pressures on the pharmaceutical industry ó from shrinking pipelines to rising costs, reimbursement issues, and regulatory pressures ó mean companies have to find ways to focus on the projects that will meet corpora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Year in Review Continuing regulatory scrutiny, an economy yet to rebound, and evolving world events are some of the hallmarks for 2003. As 2004 approaches, PharmaVOICE asked how the trends and challenges of 2003 have impacted your business and how these market factors...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
January 2004 PharmaVOICE The forum for the industry executive portfolio management Strategies improving patient compliance with Dorothy Smith Device and Diagnostic Marketing www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008
Previous
